ORIC Pharmaceuticals (ORIC) News Today → Dems have chosen Biden replacement? (From Paradigm Press) (Ad) Free ORIC Stock Alerts $8.99 +0.06 (+0.67%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 1 at 6:12 AM | americanbankingnews.comORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up to $8.45June 1 at 3:38 AM | marketbeat.comORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Average Recommendation of "Buy" from AnalystsShares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC - Get Free Report) have been given an average rating of "Buy" by the six analysts that are presently covering the firm, MarketBeat Ratings reports. Six analysts have rated the stock with a buy recommendation. The average 1 year price target among bMay 29, 2024 | globenewswire.comORIC Pharmaceuticals to Participate in Upcoming Investor ConferencesMay 28, 2024 | americanbankingnews.comORIC Pharmaceuticals (NASDAQ:ORIC) Earns "Overweight" Rating from Cantor FitzgeraldMay 26, 2024 | benzinga.comORIC Pharmaceuticals Stock (NASDAQ:ORIC), Insider Trading ActivityMay 15, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Up 5.5%ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 5.5%May 11, 2024 | marketbeat.comMonaco Asset Management SAM Trims Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)Monaco Asset Management SAM lessened its holdings in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) by 27.2% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 280,000 shares of the compMay 10, 2024 | marketbeat.comORIC Pharmaceuticals, Inc. to Post Q1 2025 Earnings of ($0.47) Per Share, HC Wainwright Forecasts (NASDAQ:ORIC)ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2025 EPS estimates for ORIC Pharmaceuticals in a note issued to investors on Wednesday, May 8th. HC Wainwright analyst R. Burns anticipates that the company will post earnings perMay 8, 2024 | markets.businessinsider.comBuy Rating on Oric Pharmaceuticals Amidst Strong Financials and Promising Clinical PipelineMay 8, 2024 | morningstar.comORIC Pharmaceuticals IncMay 8, 2024 | finance.yahoo.comWe Think ORIC Pharmaceuticals (NASDAQ:ORIC) Can Afford To Drive Business GrowthMay 7, 2024 | markets.businessinsider.comBuy Rating Affirmed for Oric Pharmaceuticals Amid Promising Clinical Data and Strong Financial PositionMay 7, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Stoke Therapeutics (STOK), Oric Pharmaceuticals (ORIC)May 7, 2024 | marketbeat.comORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Given Consensus Recommendation of "Buy" by AnalystsORIC Pharmaceuticals, Inc. (NASDAQ:ORIC - Get Free Report) has been assigned a consensus rating of "Buy" from the six brokerages that are currently covering the firm, Marketbeat reports. Six equities research analysts have rated the stock with a buy rating. The average 12 month target price amongMay 7, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 6.5%ORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Up 6.5%May 6, 2024 | investorplace.comORIC Stock Earnings: ORIC Pharmaceuticals Beats EPS for Q1 2024May 6, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 3.5%ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 3.5%May 6, 2024 | globenewswire.comORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational UpdatesMay 3, 2024 | globenewswire.comORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)April 30, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 5.8%ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 5.8%April 24, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 5.6%ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 5.6%April 18, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Trading Down 4%ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 4%April 17, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Shares Up 4.2%ORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Up 4.2%April 15, 2024 | globenewswire.comORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLCApril 8, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 2.6% ORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 2.6%April 8, 2024 | globenewswire.comORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual MeetingApril 5, 2024 | globenewswire.comORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)April 4, 2024 | globenewswire.comORIC Pharmaceuticals to Participate in Upcoming Investor ConferencesApril 1, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Trading Down 6.3%ORIC Pharmaceuticals (NASDAQ:ORIC) Trading Down 6.3%March 29, 2024 | seekingalpha.comORIC Pharmaceuticals: Rally Seems OverdoneMarch 27, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) PT Lowered to $18.00JPMorgan Chase & Co. decreased their target price on ORIC Pharmaceuticals from $19.00 to $18.00 and set an "overweight" rating for the company in a research report on Wednesday.March 21, 2024 | markets.businessinsider.comOric Pharmaceuticals: Sustained Buy Rating Amid Strong Financials and Upcoming CatalystsMarch 21, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up Following Analyst UpgradeORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up After Analyst UpgradeMarch 21, 2024 | marketbeat.comHC Wainwright Increases ORIC Pharmaceuticals (NASDAQ:ORIC) Price Target to $21.00HC Wainwright lifted their price objective on ORIC Pharmaceuticals from $15.00 to $21.00 and gave the stock a "buy" rating in a research report on Thursday.March 14, 2024 | investing.comORIC Pharmaceuticals stock target raised to $17 on strong prospectsMarch 13, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Trading 7.9% Higher ORIC Pharmaceuticals (NASDAQ:ORIC) Trading Up 7.9%March 13, 2024 | seekingalpha.comORIC Pharmaceuticals: Mid-2024 Prostate Cancer Program Update Could Lead To GainsMarch 12, 2024 | finance.yahoo.comORIC Pharmaceuticals Inc (ORIC) Reports Q4 and Full Year 2023 Financial ResultsMarch 12, 2024 | marketbeat.comEuclidean Capital LLC Raises Holdings in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)Euclidean Capital LLC boosted its stake in shares of ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC - Free Report) by 32.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 989,410 shaMarch 12, 2024 | markets.businessinsider.comThese Analysts Revise Their Forecasts On ORIC Pharmaceuticals After Q4 ResultsMarch 12, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Issues Earnings Results, Hits EstimatesORIC Pharmaceuticals (NASDAQ:ORIC - Get Free Report) released its quarterly earnings results on Monday. The company reported ($0.49) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.49).March 11, 2024 | msn.comORIC Pharmaceuticals GAAP EPS of -$0.49March 11, 2024 | globenewswire.comORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational UpdatesMarch 8, 2024 | finance.yahoo.comORIC Pharmaceuticals Inc CEO Jacob Chacko Sells 40,000 SharesMarch 8, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 5.5% ORIC Pharmaceuticals (NASDAQ:ORIC) Stock Price Down 5.5%March 7, 2024 | finance.yahoo.comORIC Mar 2024 2.500 putMarch 6, 2024 | finance.yahoo.comORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma ConferenceMarch 6, 2024 | globenewswire.comORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma ConferenceMarch 6, 2024 | globenewswire.comORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma ConferenceMarch 6, 2024 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Hits New 12-Month High at $16.10ORIC Pharmaceuticals (NASDAQ:ORIC) Reaches New 1-Year High at $16.10 Get ORIC Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ORIC and its competitors with MarketBeat's FREE daily newsletter. Email Address Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached. Secure Your Spot Now ORIC Media Mentions By Week ORIC Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORIC News Sentiment▼0.670.76▲Average Medical News Sentiment ORIC News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORIC Articles This Week▼62▲ORIC Articles Average Week Get ORIC Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ORIC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Phathom Pharmaceuticals News Today Innate Pharma News Today Arcutis Biotherapeutics News Today Karyopharm Therapeutics News Today BioXcel Therapeutics News Today Bausch Health Companies News Today Rhythm Pharmaceuticals News Today Deciphera Pharmaceuticals News Today Agios Pharmaceuticals News Today Amneal Pharmaceuticals News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORIC) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ORIC Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
